Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
success tags : Results save search
Shareholders Led by Yi Zhang Announce Successful Results of Removal of Directors and Election of New Directors of YS Biopharma Co., Ltd.
Published: 2024-02-16 (Crawled : 23:00) - prnewswire.com
YS | News | $0.7013 -17.98% -21.92% 420K
|
n/a
| Email alert
Add to watchlist
biopharma removal results
New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval
Published: 2024-02-01 (Crawled : 21:00) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 2.78%
H: 6.05%
C: 4.59%
fda fibromyalgia approval hope trial results
Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
CDLX | $12.21 2.26% 2.21% 830K
|
Technology Services
|
| O: 22.7%
H: 11.16%
C: 1.55%
results
Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
Published: 2024-01-17 (Crawled : 14:30) - biospace.com/
PTPI | $0.6849 -1.86% -1.9% 150K
|
|
| O: 21.31%
H: 5.41%
C: -19.59%
stendra positive pharmaceuticals results study
Ring Energy Announces Successful Results of Senior Credit Facility Fall 2023 Redetermination and Final Payment for Founders Property Acquisition
Published: 2023-12-21 (Crawled : 12:00) - globenewswire.com
REI | $2.02 2.54% 0.0% 1.4M
|
Energy Minerals
|
| O: 2.0%
H: 0.65%
C: -1.31%
energy payment acquisition results
Sight Sciences Announces the Publication of Successful Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease
Published: 2023-12-18 (Crawled : 21:00) - globenewswire.com
SGHT | $5.14 -1.91% -1.95% 130K
|
|
| O: -0.3%
H: 8.84%
C: 2.44%
tearcare disease publication treatment sciences eye trial results
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
Published: 2023-11-29 (Crawled : 13:30) - globenewswire.com
DYAI A | $1.61 1.26% 1.24% 14K
|
Health Technology
|
| O: -0.85%
H: 5.71%
C: -2.29%
candidate vaccine trial results
Pacific Blue Cross and HealthTech Connex report successful results in brain injury rehabilitation project
Published: 2023-11-02 (Crawled : 21:00) - heliusmedical.com
HSDT | $5.01 -1.96% -2.0% 4.5K
|
Health Technology
|
| O: 2.21%
H: 0.13%
C: 0.0%
report blue results
UPDATE – 5E Advanced Materials Announces Successful Delivery of Step-Rate Testing Results
Published: 2023-10-26 (Crawled : 18:00) - globenewswire.com
FEAM | $1.19 0.0% 120K
|
n/a
|
| O: 1.2%
H: 0.0%
C: -3.17%
update results
5E Advanced Materials Announces Successful Delivery of Step-Rate Testing Results
Published: 2023-10-26 (Crawled : 13:00) - globenewswire.com
FEAM | $1.19 0.0% 120K
|
n/a
|
| O: 1.2%
H: 0.0%
C: -3.17%
results
Sight Sciences Announces Presentation of Successful Phase I Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease at the American Academy of Optometry Annual Meeting
Published: 2023-10-12 (Crawled : 20:00) - globenewswire.com
SGHT | $5.14 -1.91% -1.95% 130K
|
|
| O: -0.77%
H: 1.81%
C: -2.07%
tearcare disease presentation treatment sciences meeting eye trial results
Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Update on CEO Succession Plan
Published: 2023-09-28 (Crawled : 13:00) - dynatronics.com
DYNT | $0.52 -6.53% -6.98% 210K
|
Health Technology
|
| O: -3.19%
H: 30.94%
C: 0.72%
ceo year corporation update financial results
Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results
Published: 2023-07-25 (Crawled : 14:20) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K
|
Health Technology
| Email alert
Add to watchlist
cancer treatment trial results
Sight Sciences Announces Positive Results and Primary Endpoint Successfully Met in SAHARA
Published: 2023-07-20 (Crawled : 13:00) - biospace.com/
SGHT | $5.14 -1.91% -1.95% 130K
|
|
| O: 0.52%
H: 1.68%
C: -4.39%
positive sciences results
Sight Sciences Announces Positive Results and Primary Endpoint Successfully Met in SAHARA, a Randomized Controlled Clinical Trial Comparing Interventional Eyelid Procedures Enabled by TearCare® Technology to Restasis¹ for the Treatment of Dry Eye
Published: 2023-07-20 (Crawled : 12:00) - globenewswire.com
SGHT | $5.14 -1.91% -1.95% 130K
|
|
| O: 0.52%
H: 1.68%
C: -4.39%
tearcare positive treatment sciences eye technology trial results
Exela Technologies, Inc. Announces Successful Results and Expiration of Exchange Offer and Consent Solicitation and Satisfaction of 2023 Maturities
Published: 2023-07-12 (Crawled : 13:00) - globenewswire.com
XELA | $1.965 -1.75% -1.78% 99K
|
Technology Services
|
| O: 3.21%
H: 7.38%
C: 0.97%
results
Ring Energy Announces Successful Results of Senior Credit Facility Spring 2023 Redetermination
Published: 2023-06-27 (Crawled : 11:00) - globenewswire.com
REI | $2.02 2.54% 0.0% 1.4M
|
Energy Minerals
|
| O: 0.58%
H: 1.05%
C: -0.58%
energy spring results
Vistagen Announces Results of Successful U.S. Phase 1 Study of Itruvone (PH10), Enabling U.S. Phase 2B Development for Treatment of Major Depressive Disorder
Published: 2023-06-21 (Crawled : 14:00) - biospace.com/
VTGN | $4.77 1.49% 1.47% 150K
|
Health Technology
|
| O: -1.55%
H: 6.28%
C: -5.76%
ph10 treatment enabling results study
Lesaka Reports Third Quarter 2023 Results – Continued improvement in financial performance further evidences successful turnaround
Published: 2023-05-09 (Crawled : 20:00) - globenewswire.com
LSAK | $4.11 -2.38% -2.43% 10K
|
Information
|
| O: -1.18%
H: 3.88%
C: -2.09%
financial results
Sterling Reports First Quarter 2023 Results with Successful Execution Towards 2023 Goals and Long-Term Strategy
Published: 2023-05-09 (Crawled : 11:00) - globenewswire.com
STER | $14.975 1.39% 1.37% 400K
|
|
| O: -0.09%
H: 10.21%
C: 7.9%
results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.